Interestingly, while the in vitro growth-inhibitory effect of fulvestrant alone was much stronger than that of Senexin B alone, the in vivo effects of the two compounds were similar, possibly reflecting a role of CDK8/19 in tumor-stromal interactions [13]. Here, CDK8 is linked to neoplasm.